Skip to main content
  • twitter
  • phone
  • email
  • 1-800-4-CANCER
  • Live Help
Hit enter to search or ESC to close
Close Search
Metro Minnesota Community Oncology Research Consortium
  • LOGIN
search
Menu
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • LOGIN
  • DONATE
  • search
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • DONATE
  • 1-800-4-CANCER
  • Live Help
Tag

minnesota oncology – coon rapids

Recent Posts

  • DCIS: RECAST (Open at HCMC Only)
  • MM1YA-S01: A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7+3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia as Determined by myeloMATCH; A myeloMATCH Clinical Trial
  • EA3231, A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em
  • S2312: A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCrPC), Stratified by Aggressive Variant Signature (NCT# 06470243)
  • ELEGANT/STML-ELA-0422

Recent Comments

No comments to show.

Contact Us

Phone: 952-993-1517 | Fax: 952-993-1550

Email: mmcorc@healthpartners.com

Mailing: 3800 Park Nicollet Blvd., St. Louis Park, MN 55416

Physical: 6465 Wayzata Blvd., Suite 310, St Louis Park, MN 55426

Download the App

Download on the App Store

The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. Local physician have access to the newest advances in cancer research. The MMCORC links community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials.

The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. 7 Research Bases Develop and coordinate clinical trials and cancer care research for 32 Community Sites and 14 Minority/Underserved Community Sites to bring NCI approved trials to patients including 1,000+ locations at diverse, community-based hospitals, private practices and more.

The Minnesota Cancer Clinical Trials Network (MNCCTN) is a cancer clinical trials network with locations across Minnesota, funded by the Minnesota legislature as part of the University of Minnesota's overall MnDRIVE Strategic Investment Request. Led by the Masonic Cancer Center, University of Minnesota, MNCCTN partner organizations like MMCORC aim to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.

© 2025 Metro Minnesota Community Oncology Research Consortium.

  • twitter
  • phone
  • email